ULBI SHAREHOLDER ALERT: ADEMI LLP INVESTIGATES WHETHER BUYOUT FAIRLY VALUES ULTRALIFE CORPORATION
ULBI shareholders will receive just $16.00 per share in a transaction with an enterprise value of approximately $320 million; Ademi LLP is investigating th